Requires public hospitals to establish auto-immune disease treatment centers; authorizes the commissioner of health, with the assistance of the office of health equity, to make funds available to public hospitals for such purpose.
Summary
Bill S06034 mandates that all public hospitals in New York establish auto-immune disease treatment centers. The bill defines these centers as facilities dedicated to the treatment of auto-immune diseases, which may include construction, renovation, and equipping of such centers. The New York State Commissioner of Health is tasked with overseeing the implementation of this requirement and is authorized to allocate funds to support the establishment of these centers. Additionally, the Office of Health Equity will assist in the distribution of funds and the development of methodologies for their allocation.
Impact
The bill will significantly impact public health law in New York by establishing a new requirement for public hospitals, which are defined as those operated by counties or municipalities and receiving state funding. This will likely lead to increased funding and resources dedicated to the treatment of auto-immune diseases, potentially improving healthcare access and outcomes for affected individuals. The establishment of treatment centers may also influence the allocation of state health resources and funding priorities moving forward.
Sentiment
The sentiment surrounding Bill S06034 appears to be generally supportive, as it addresses a critical area of public health by focusing on auto-immune diseases. However, there may be concerns regarding the funding and resources required to implement these centers effectively, as well as the potential impact on existing healthcare services. Discussions in committee may reflect a desire for clarity on funding mechanisms and the operationalization of the treatment centers.
Contention
Notable points of contention may arise around the funding sources for the establishment and maintenance of these treatment centers. Some stakeholders may express concerns about the financial burden on public hospitals, especially those already facing budget constraints. Additionally, there may be differing opinions on the prioritization of auto-immune disease treatment compared to other pressing health issues within the state.
Same As
Requires public hospitals to establish auto-immune disease treatment centers; authorizes the commissioner of health, with the assistance of the office of health equity, to make funds available to public hospitals for such purpose.
Requires public hospitals to establish auto-immune disease treatment centers; authorizes the commissioner of health, with the assistance of the office of health equity, to make funds available to public hospitals for such purpose.
An Act Establishing Licensure For Long-term Acute Care Hospitals And Requiring The Department Of Public Health To Study The Designation Of Long-term Care Facilities And Chronic Disease Hospitals.
Relates to the publication of immunization information; requires schools to provide immunization information to the commissioner of health; requires the department of health to make immunization information, including rates of immunization, available on its website.
Authorizes the commissioner of health to make grants for purposes of preventing transmission of tick-borne diseases on public lands frequented by humans; requires the commissioner to submit an annual report on the performance of programs funded by such grants.
Authorizes the commissioner of health to make grants for purposes of preventing transmission of tick-borne diseases on public lands frequented by humans; requires the commissioner to submit an annual report on the performance of programs funded by such grants.
Commissioner of health required to establish a provider orders for life-sustaining treatment program, rulemaking authorized, data classified, immunity established for certain acts, and money appropriated.
Authorizes a licensed pharmacist to administer any recommendations made by the commissioner of health pertaining to a vaccine that has been authorized by the federal Food and Drug Administration; relates to insurance coverage for immunizations; removes the requirement to follow the advisory committee on immunization practices of the centers for disease control and prevention recommendation for immunization against meningococcal disease.
Requires the health equity council to issue mandates related to the treatment of sickle cell disease; requires the commissioner of health to adhere to and act upon the recommendations and mandates of the health equity council.
Authorizes a licensed pharmacist to administer any recommendations made by the commissioner of health pertaining to a vaccine that has been authorized by the federal Food and Drug Administration; relates to insurance coverage for immunizations; removes the requirement to follow the advisory committee on immunization practices of the centers for disease control and prevention recommendation for immunization against meningococcal disease.